The two hypoprothrombinemic effect of coumarin anticoagulants in our series
DOI:
https://doi.org/10.15381/anales.v43i3.6342Abstract
Since the introduction of coumarin anticoagulants in clinical practice in 1941 (1.2), the end of the experimental works of Karl Paul Link and his group supplement (3.4), its use has spread dramatically. Indeed; the protection offered by these drugs as antagonists of thromboembolic processes confers singular values in all cases, the common denominator is given by those. However, rigorous control required for proper dosage simultaneously ensure optimal antithrombotic effect and bleeding safety, has been perhaps one of the factors which, among us, its use is very restricted.Downloads
Published
1960-09-19
Issue
Section
Trabajos originales
License
Copyright (c) 1960 Carlos Forno, Carlos M. Vidurrizaga, Manuel Figallo
![Creative Commons License](http://i.creativecommons.org/l/by-nc-sa/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Those authors who have publications with this magazine accept the following terms:
- Authors will retain their copyrights and guarantee the journal the right of first publication of their work, which will be simultaneously subject to Creative Commons Attribution License that allows third parties to share the work as long as its author and its first publication this magazine are indicated.
- Authors may adopt other non-exclusive licensing agreements for the distribution of the version of the published work (eg, deposit it in an institutional electronic file or publish it in a monographic volume) provided that the initial publication in this magazine is indicated.
- Authors are allowed and recommended to disseminate their work over the Internet (eg: in institutional telematic archives or on their website) before and during the submission process, which It can produce interesting exchanges and increase quotes from the published work. (See El efecto del acceso abierto ).
How to Cite
1.
Forno C, Vidurrizaga CM, Figallo M. The two hypoprothrombinemic effect of coumarin anticoagulants in our series. An Fac med [Internet]. 1960 Sep. 19 [cited 2024 Aug. 16];43(3):609-17. Available from: https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/6342